SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.
Contract Category
4 federal contract opportunities classified as Assay Development.
AI Summary
The FDA plans to award a Sole Source Firm Fixed Price Purchase Order to MIMETAS B.V. for the development of a 3D human blood-brain barrier formation assay. This notice is not a request for competitive proposals, but interested parties may submit capability statements by June 12, 2026.
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The CDC intends to award a sole source contract to Emory University for the development and validation of novel ARV detection methods. This includes the collection of biological specimens for analysis. The opportunity is not open for competitive quotations, but responses will be considered within 15 days of the notice.
GA
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The ASSURE program seeks to develop innovative assays for evaluating immune responses to infections and vaccinations. This solicitation aims to establish new assay technologies for BARDA and vaccine developers, focusing on comprehensive immune status assessment related to CBRN threats and emerging infectious diseases.
DC
AI Summary
The NIH is seeking experienced consultants in assay development to provide technical guidance for drug discovery programs, including the HEAL Initiative and the Blueprint Neurotherapeutics Program. This opportunity focuses on optimizing non-addictive therapies and supporting neuroscience-related drug development effort…
MD
Common questions about finding and winning Assay Development government contracts.